| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On October 29, 2004
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1978N-0064
|
| OTC Antiperspirant
|
|
|
|
|
| 1998D-0785
|
| Medical imaging drugs and biologics
|
|
|
|
|
| 2000N-1571
|
| Enrofloxacin for Poultry: Opportunity for Hearing
|
|
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
|
|
| 2001P-0345
|
| Listing the color additive yellow #5 for use in food/Drug
|
|
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| 2003P-0270
|
| Prohibit False and Misleading Labeling
|
|
|
|
|
| 2004N-0181
|
| Critical Path Initiative
|
|
|
|
|
| 2004P-0127
|
| ANADA suitability for ANTIROBE (clindamycin hydrochloride) capsules for dogs and cats (NADA 120-161)
|
|
|
|
|
| 2004P-0220
|
| determine that the reference listed drug Zithromax (azithromycin) oral capsules,NDAS 50-670 was not withdrawn from sale for reasons related to safety or effectiveness
|
|
|
|
|
| 2004P-0429
|
| Revoke 21 C.F.R. Part 11 in its entirety, and purse implementation of electronic record and signature
|
|
|
|
|
| 2004P-0457
|
| Reclassifcation of the Buechel-Pappas Unconstrained Ankle Prosthesis
|
|
|
|
|
| 2004P-0483
|
| Petition for rulemaking on Nutrition Labeling for food and beverages sold in single-serving containers
|
|
|
|
|
| 1978N-0064
|
| OTC Antiperspirant
|
|
|
| EMC 2
|
| B. Sachau
|
| Vol #:
|
| 53
|
|
|
|
|
| 1998D-0785
|
| Medical imaging drugs and biologics
|
|
|
|
|
| C
33
|
| General Electric COmpany (GE Healthcare)
|
| Vol #:
|
| 6
|
|
|
|
|
| 2000N-1571
|
| Enrofloxacin for Poultry: Opportunity for Hearing
|
|
|
|
|
| EXB 661
|
| Bayer Corporation
|
| Vol #:
|
| 458
|
|
|
|
|
| EXB 662
|
| Bayer Corporation
|
| Vol #:
|
| 458
|
|
|
|
|
| EXB 663
|
| Bayer Corporation
|
| Vol #:
|
| 458
|
|
|
|
|
| EXB 664
|
| Bayer Corporation
|
| Vol #:
|
| 458
|
|
|
|
|
| EXB 665
|
| Bayer Corporation
|
| Vol #:
|
| 458
|
|
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
|
|
| C
2040
|
| Massachusetts Emergency Contraception Network
|
| Vol #:
|
| 295
|
|
|
|
|
| EMC 10928
|
| N. Schroeder
|
| Vol #:
|
| 296
|
|
|
|
|
| EMC 10929
|
| E. Taylor
|
| Vol #:
|
| 296
|
|
|
|
|
| EMC 10930
|
| J. Kilburn
|
| Vol #:
|
| 296
|
|
|
|
|
| EMC 10931
|
| G. Longinetti
|
| Vol #:
|
| 296
|
|
|
|
|
| EMC 10932
|
| A. Philbin
|
| Vol #:
|
| 296
|
|
|
|
|
| EMC 10933
|
| M. Miracle
|
| Vol #:
|
| 296
|
|
|
|
|
| EMC 10934
|
| C. Textoris
|
| Vol #:
|
| 296
|
|
| | | | | | | | |
|
|
|
|
| 2004P-0220
|
| determine that the reference listed drug Zithromax (azithromycin) oral capsules,NDAS 50-670 was not withdrawn from sale for reasons related to safety or effectiveness
|
|
|
|
|
| LET
1
|
| HFD-005 to Wapner,Newman,Wigrizer,Brecher
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004P-0429
|
| Revoke 21 C.F.R. Part 11 in its entirety, and purse implementation of electronic record and signature
|
|
|
|
|
| EMC
1
|
| Society of Quality Assurance Computer Validation Initiative Committee (CVIC)
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004P-0457
|
| Reclassifcation of the Buechel-Pappas Unconstrained Ankle Prosthesis
|
|
|
|
|
| SUP
1
|
| Endotec, Incorporated
|
| Vol #:
|
| 3
|
|
|
|
|
| 2004P-0483
|
| Petition for rulemaking on Nutrition Labeling for food and beverages sold in single-serving containers
|
|
|
|
|
| ACK
1
|
| HFA-305 to Center for Science in the Public Interest
|
| Vol #:
|
| 1
|
|
|
|
|
| CP
1
Attachment
|
| Center for Science in the Public Interest
|
| Vol #:
|
| 1
|
|
